BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Thrombotargets Corp. and Specs achieve milestone in their Drug Discovery collaboration and announce the beginning of a new Anticoagulant program.

Thrombotargets and Specs to start Hit to Lead after their collaboration yields first milestone.

North Carolina, April 23rd, 2007. - Since Specs (Delft, The Netherlands) and Thrombotargets Corp (Durham, NC) announced their Drug Discovery Collaboration Agreement, in 2006, Thrombotargets has carried out the HTS of specific library provided by Specs with its powerful and innovative BioPlatformScreen ™ technology. Thrombotargets has been able to identify some new anticoagulant small molecules.

The discovered hits exert an important potency and its therapeutical window is much wider than those of Heparins, Low Molecular Weight Heparins (LMWH) and other standard treatments. “We are very excited and feel very optimistic regarding this success in our collaboration with Specs. In addition, these new hits will balance our present peptide-based and antibody-based anticoagulant programs” said Dr. Javier Pedreño, President and CEO of Thrombotargets Corp.
“We are confident that the combined power of our high quality screening compounds library and Thrombotargets’ BioPlatformScreen™ Technology will generate even more new projects“ said Johan Tijhuis, Specs’ CEO.

Thrombotargets and Specs have decided to continue its Drug Discovery collaboration to take advantage of their respective technologies and know-how, in the Hit to Lead and Lead Optimization process.

Contact

Luis Caveda
Chief Operating Officer
luiscaveda@thrombotargets.com

 

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreements

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Stafford House, 10 Prince of Wales Road, Dorchester, Dorset, DT1 1PW, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.